REG - SAGA Plc - Delay to publication of H1 2024 results

SagaAnnouncement

01/10/2024 16:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241001:nRSA5273Ga&default-theme=true

RNS Number : 5273G  SAGA PLC  01 October 2024

1 October 2024

 

 

Delay to publication of H1 2024 results

 

 

Saga plc continues to explore partnership opportunities to support the Group's
capital-light growth ambitions, crystallise value and enhance long-term
returns for shareholders.

 

While this process remains ongoing, the Group today announces that it is
delaying its half year results, which were due to be published on 2 October
2024. The results will be announced at the earliest possible opportunity. Saga
confirms that performance for the first half is in line with expectations and
the Group remains on track for the full year.

 

 

 

 Saga plc
 Emily Roalfe, Director of Investor Relations  Tel: 07732 093 007
                                               Email: emily.roalfe@saga.co.uk (mailto:emily.roalfe@saga.co.uk)
 Headland Consultancy
 Susanna Voyle                                 Tel: 07980 894 557
 Will Smith                                    Tel: 07872 350 428
                                               Tel: 020 3805 4822
                                               Email: saga@headlandconsultancy.com (mailto:saga@headlandconsultancy.com)

 

Notes to editors

 

Saga is a specialist in the provision of products and services for people over
50. The Saga brand is one of the most recognised and trusted in the UK. Saga
is known for its high level of customer service and its high quality,
award-winning products and services including cruises and holidays, insurance,
personal finance and publishing. www.saga.co.uk (http://www.saga.co.uk/)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCZZMGGKMMGDZM